View Post

U of S ‘assassin antibody’ shows promise in killing cancer

In Clinical Studies News by Barbara Jacoby

By: Chris Vandenbreekel From: .cjme.com A promising research breakthrough at the University of Saskatchewan could end up being a cure for colorectal cancer. A research team has developed an “assassin antibody” that attaches itself to colorectal cancer cells and destroys them with an astonishing success rate. “We’ve had up to 80 per cent of animals completely disease free,” research lead …

View Post

Racial disparities in US cancer deaths are shrinking, study finds

In In The News by Barbara Jacoby

Posted By: CNN Wire From: wtvr.com Racial disparities in cancer deaths between black and white patients in the United States are receding — but more progress is needed to completely close the gap for some cancer types and age groups, according to a new study. Among men, the overall cancer death rate was 47% higher for blacks than for whites …

View Post

New virus could help destroy cancer

In In The News by Barbara Jacoby

By: Chiara Townley From: medicalnewstoday.com A new study examines the behavior of a cancer-killing virus that fits tumor cells perfectly and leaves healthy cells intact. Cancer is a chronic disease that kills millions of people worldwide. According to the World Health Organization (WHO), cancer is the second leading cause of death globally and is likely to be responsible for more …

View Post

Cancer survivors more prone to obesity, especially certain types

In In The News by Barbara Jacoby

By: Robert Preidt From: cbsnews.com Obesity is more common among cancer survivors in the United States than in the general population, a new study finds. The problem is particularly high among survivors of colorectal and breast cancer, the study authors said. The researchers analyzed data gathered from nearly 539,000 American adults between 1997 and 2014. Among people with no history …

View Post

Global Non-Hematological Cancers Market Will Almost Double to $141 Billion by 2021

In In The News by Barbara Jacoby

The global treatment market for non-hematological cancers, which includes breast, colorectal, lung and prostate cancers, among others, will almost double from $72.9 billion in 2014 to $140.8 billion in 2021, at a compound annual growth rate (CAGR) of 9.9%, according to business intelligence provider GBI Research. The company’s latest report* states that this robust growth will occur in spite of …

View Post

How Dogs Can Sniff Out Diabetes and Cancer

In In The News by Barbara Jacoby

By: Liz Langley From: nationalgeographic.com The Force is strong in Jedi. The black Labrador retriever recently detected a drop in blood sugar in 7-year-old Luke Nuttall, who has Type 1 diabetes. His glucose monitor didn’t pick it up, but Jedi did—and woke up Luke’s mother, Dorrie Nuttall, as he was trained. The California family’s amazing story, which went viral on Facebook, made NatGeo’s own Nicole Werbeck wonder, “How do dogs …

View Post

Seattle lab’s vaccine could be cancer breakthrough

In In The News by Barbara Jacoby

By: John Knicely From: myajc.com Etubics Corporation, a biopharmaceutical company in Seattle’s Lower Queen Anne neighborhood, is moving forward after a major breakthrough in treating cancer patients. A new type of treatment more than doubled the life span of some cancer patients. Now, the lab has the backing of the National Cancer Institute in testing its immunotherapy for cancer patients. …

View Post

Overweight Colorectal Cancer Patients Survive Longer

In In The News by Barbara Jacoby

By: Sara G. Miller From: lifescience.com People with advanced colorectal cancer who are overweight or obese may survive longer than their thinner counterparts, a new study suggests. Researchers found that, on average, patients with a body mass index (BMI) of 25 or higher lived two and a half months longer after starting their treatment than patients with a lower BMI. …

View Post

New Biomarkers Might Help Personalize Metastatic Colorectal Cancer Treatment

In In The News by Barbara Jacoby

From: UC San Diego Health Sciences News New Biomarkers Might Help Personalize Metastatic Colorectal Cancer Treatment Low levels of two genes predicts positive response to chemotherapy and longer survival times Metastatic colorectal cancer patients tend to live longer when they respond to the first line of chemotherapy their doctors recommend. To better predict how patients will respond to chemotherapy drugs …